LTRN
Lantern Pharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
LTRN fundamentals
Lantern Pharma (LTRN) expects to report earnings on Aug 14, 2025, with estimated revenue of -- (YoY 0.00%), and EPS at -0.49 (YoY -6.52%).
Revenue estimate / YoY
--
0.00%
EPS estimate / YoY
-0.49
-6.52%
Report date
Aug 14, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Lantern Pharma (LTRN) key financial stats and ratios, covering profitability, financial health, and leverage.
Lantern Pharma (LTRN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Lantern Pharma (LTRN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Lantern Pharma (LTRN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Lantern Pharma (LTRN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Lantern Pharma (LTRN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Lantern Pharma beat or miss consensus estimates last quarter?What were the key takeaways from Lantern Pharma’s earnings call?What is Lantern Pharma’s gross profit margin?What factors drove the changes in Lantern Pharma’s revenue and profit?What guidance did Lantern Pharma’s management provide for the next earnings period? What is Lantern Pharma’s latest dividend and current dividend yield?What does Lantern Pharma do and what are its main business segments?How were Lantern Pharma’s latest financial results overall?